HFA suspension formulations containing an anticholinergic

Details HFA suspension formulations containing an anticholinergic HFA suspension formulations containing an anticholinergic

2007-12-25

2007-12-25

Richter, Johann (Department: 1616)

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

C424S046000, C514S291000, C514S629000

Reexamination Certificate

active

10392559

ABSTRACT:
The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of (1α,2β,4β,5α,7β)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane-bromide.

REFERENCES:
patent: 4042700 (1977-08-01), Banholzer et al.
patent: 4608377 (1986-08-01), Banholzer et al.
patent: 4783534 (1988-11-01), Banholzer
patent: 5610163 (1997-03-01), Banholzer et al.
patent: 5654314 (1997-08-01), Banholzer et al.
patent: 5770738 (1998-06-01), Banholzer et al.
patent: 5952505 (1999-09-01), Banholzer
patent: 5955058 (1999-09-01), Jager et al.
patent: 6045778 (2000-04-01), Jager et al.
patent: 6475467 (2002-11-01), Keller et al.
patent: 6486321 (2002-11-01), Banholzer et al.
patent: 6506900 (2003-01-01), Banholzer et al.
patent: 6537524 (2003-03-01), Hasan et al.
patent: 6777423 (2004-08-01), Banholzer et al.
patent: 6908928 (2005-06-01), Banholzer et al.
patent: 2002/0183292 (2002-12-01), Pairet et al.
patent: 2002/0193392 (2002-12-01), Schmelzer et al.
patent: 2003/0125350 (2003-07-01), Hassan et al.
patent: 2004/0002510 (2004-01-01), Bender et al.
patent: 2004/0087793 (2004-05-01), Banholzer et al.
patent: 2006/0083692 (2006-04-01), Hassan et al.
patent: WO 00/07567 (2000-02-01), None
patent: WO 01/78743 (2001-10-01), None
patent: WO 02/30928 (2002-04-01), None
patent: WO 02/36106 (2002-05-01), None
patent: WO 02/36106 (2002-05-01), None
patent: WO 02/38154 (2002-05-01), None
Jager, P. D. et al; “Stabilized Medicinal Aerosol Solution Formulations”; U.S. Appl. No. 07/987,852, filed Dec. 9, 1992.
Bryn, S., et al: “Review - Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations” Pharmaceutical Research, vol. 12, No. 7, 1995, pp. 945-953.

Affiliated with

Also associated with

Rating

HFA suspension formulations containing an anticholinergic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HFA suspension formulations containing an anticholinergic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HFA suspension formulations containing an anticholinergic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3889571